Conceptio › Archive › Brookings

Brookingsmetadata only

Comments on biosimilar streamlining efforts and context on commercial barriers to competition

Brookings Institution

Brookings · Other

Open Source ↗

economics governance policy

policy, economics, governance

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Comments on DEA’s proposed rule on manufacturing and procurement quotas#410925
Options for modernization of traditional Medicare#426521
Comments on the implementation of Medicaid community engagement (work) requirements#429537
Medicaid work requirements built on invented evidence will harm the people they claim to help#435608
Response to Senate Finance Committee request for information on policies for lowering drug prices#463524

Record · ID 171382
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.